HK2 and diffuse large B-cell lymphoma: Indeed, the subsequent luciferase reporter and CHIP assay confirmed the binding site of HIF-1α of the HK2 promoter, which further demonstrated the underlying mechanism by which LARS positively regulated DLBCL progression.